427 related articles for article (PubMed ID: 18497067)
1. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
3. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
4. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
van de Stolpe A; Slycke AJ; Reinders MO; Zomer AW; Goodenough S; Behl C; Seasholtz AF; van der Saag PT
Mol Endocrinol; 2004 Dec; 18(12):2908-23. PubMed ID: 15345745
[TBL] [Abstract][Full Text] [Related]
6. Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells.
Tonetti DA; Rubenstein R; DeLeon M; Zhao H; Pappas SG; Bentrem DJ; Chen B; Constantinou A; Craig Jordan V
J Steroid Biochem Mol Biol; 2003 Oct; 87(1):47-55. PubMed ID: 14630090
[TBL] [Abstract][Full Text] [Related]
7. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
8. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
9. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
[TBL] [Abstract][Full Text] [Related]
11. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
[TBL] [Abstract][Full Text] [Related]
13. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Kim K; Thu N; Saville B; Safe S
Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
[TBL] [Abstract][Full Text] [Related]
14. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
15. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
[TBL] [Abstract][Full Text] [Related]
16. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
17. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.
Stoner M; Wormke M; Saville B; Samudio I; Qin C; Abdelrahim M; Safe S
Oncogene; 2004 Feb; 23(5):1052-63. PubMed ID: 14647449
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
19. Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance.
Wu J; Liang Y; Nawaz Z; Hyder SM
Int J Oncol; 2005 Dec; 27(6):1647-59. PubMed ID: 16273221
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
Ruohola JK; Valve EM; Karkkainen MJ; Joukov V; Alitalo K; Härkönen PL
Mol Cell Endocrinol; 1999 Mar; 149(1-2):29-40. PubMed ID: 10375015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
